Validity and reliability of the Japanese versions of cognitive and behavioral scales for irritable bowel syndrome.
Cognitive scale for functional bowel disorders
Irritable bowel syndrome
Irritable bowel syndrome-behavioral responses questionnaire
Japanese version
Journal
BioPsychoSocial medicine
ISSN: 1751-0759
Titre abrégé: Biopsychosoc Med
Pays: England
ID NLM: 101286572
Informations de publication
Date de publication:
23 Jul 2022
23 Jul 2022
Historique:
received:
29
11
2021
accepted:
24
06
2022
entrez:
23
7
2022
pubmed:
24
7
2022
medline:
24
7
2022
Statut:
epublish
Résumé
The Cognitive Scale for Functional Bowel Disorders (CS-FBD) and Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ) are a useful measures to assess cognitive-behavioral aspects in individuals with IBS. This study aimed to confirm the reliability and validity of the Japanese versions of the CS-FBD (CS-FBD-J) and IBS-BRQ (IBS-BRQ-J). Participants comprised 192 students and 22 outpatients diagnosed with irritable bowel syndrome (IBS). There were 76 students who met the diagnostic criteria for IBS and two students who received treatment for IBS. Participants completed questionnaires containing the CS-FBD-J, IBS Severity Index (IBS-SI), Visceral Sensitivity Index (VSI), 24-item Dysfunctional Attitudes Scale (DAS-24), Hospital Anxiety and Depression Scale (HADS), and Social Adaptation Self-evaluation Scale (SASS). Our exploratory factor analysis revealed that the CS-FBD-J had a unidimensional factor structure and that the factor loadings for two of the 25 items were less than 0.4. The IBS-BRQ-J had a two-factor structure, and the factor loadings for eight of the 26 items were less than 0.4. The confirmatory factor analysis for the 18-item version of IBS-BRQ-J showed that the model fit indices were not sufficient. The CS-FBD-J and IBS-BRQ-J had significant, moderate correlations with the IBS-SI and VSI in the IBS and control groups. Correlation between the DAS-24 and the CS-FBD-J was not significant. The CS-FBD-J and IBS-BRQ-J were significantly correlated to the HADS and SASS (IBS-BRQ-J) only in the IBS group. The scores of CS-FBD-J and IBS-BRQ-J showed significant group differences between the IBS patient group, non-patient IBS group, and control group. The internal consistencies of the CS-FBD-J and IBS-BRQ-J were high. The item-total correlation analysis for the CS-FBD-J and IBS-BRQ-J showed that the correlations between each item and the total score were significant. This study confirmed the reliability and validity of the 23-item version of the CS-FBS-J and the 18-item version of the IBS-BRQ-J with the deletion of items with low factor loadings. Regarding the IBS-BRQ-J, two factor structures were confirmed (factor 1: behavior obsessed with abdominal symptoms, factor 2: avoidance of abdominal symptoms and associated difficulties) although the model fit of the structure needs further study.
Sections du résumé
BACKGROUND
BACKGROUND
The Cognitive Scale for Functional Bowel Disorders (CS-FBD) and Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ) are a useful measures to assess cognitive-behavioral aspects in individuals with IBS. This study aimed to confirm the reliability and validity of the Japanese versions of the CS-FBD (CS-FBD-J) and IBS-BRQ (IBS-BRQ-J).
METHODS
METHODS
Participants comprised 192 students and 22 outpatients diagnosed with irritable bowel syndrome (IBS). There were 76 students who met the diagnostic criteria for IBS and two students who received treatment for IBS. Participants completed questionnaires containing the CS-FBD-J, IBS Severity Index (IBS-SI), Visceral Sensitivity Index (VSI), 24-item Dysfunctional Attitudes Scale (DAS-24), Hospital Anxiety and Depression Scale (HADS), and Social Adaptation Self-evaluation Scale (SASS).
RESULTS
RESULTS
Our exploratory factor analysis revealed that the CS-FBD-J had a unidimensional factor structure and that the factor loadings for two of the 25 items were less than 0.4. The IBS-BRQ-J had a two-factor structure, and the factor loadings for eight of the 26 items were less than 0.4. The confirmatory factor analysis for the 18-item version of IBS-BRQ-J showed that the model fit indices were not sufficient. The CS-FBD-J and IBS-BRQ-J had significant, moderate correlations with the IBS-SI and VSI in the IBS and control groups. Correlation between the DAS-24 and the CS-FBD-J was not significant. The CS-FBD-J and IBS-BRQ-J were significantly correlated to the HADS and SASS (IBS-BRQ-J) only in the IBS group. The scores of CS-FBD-J and IBS-BRQ-J showed significant group differences between the IBS patient group, non-patient IBS group, and control group. The internal consistencies of the CS-FBD-J and IBS-BRQ-J were high. The item-total correlation analysis for the CS-FBD-J and IBS-BRQ-J showed that the correlations between each item and the total score were significant.
CONCLUSION
CONCLUSIONS
This study confirmed the reliability and validity of the 23-item version of the CS-FBS-J and the 18-item version of the IBS-BRQ-J with the deletion of items with low factor loadings. Regarding the IBS-BRQ-J, two factor structures were confirmed (factor 1: behavior obsessed with abdominal symptoms, factor 2: avoidance of abdominal symptoms and associated difficulties) although the model fit of the structure needs further study.
Identifiants
pubmed: 35871011
doi: 10.1186/s13030-022-00244-3
pii: 10.1186/s13030-022-00244-3
pmc: PMC9308329
doi:
Types de publication
Journal Article
Langues
eng
Pagination
15Subventions
Organisme : Japan Society for the Promotion of Science
ID : 15K01685
Organisme : Japan Society for the Promotion of Science
ID : 19K11771
Informations de copyright
© 2022. The Author(s).
Références
Behav Res Ther. 2014 Apr;55:27-39
pubmed: 24584055
Behav Res Ther. 2018 Jun;105:27-35
pubmed: 29614378
Dig Dis Sci. 1998 Feb;43(2):400-11
pubmed: 9512138
J Neurogastroenterol Motil. 2016 Jan 31;22(1):102-11
pubmed: 26459461
JMIR Ment Health. 2017 Aug 10;4(3):e32
pubmed: 28798012
J Gastroenterol. 2006 May;41(5):491-4
pubmed: 16799892
Clin Gastroenterol Hepatol. 2008 Aug;6(8):899-906
pubmed: 18524691
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Biopsychosoc Med. 2014 Mar 21;8(1):10
pubmed: 24655428
Acta Neuropsychiatr. 2007 Dec;19(6):362-7
pubmed: 26953002
Eur Neuropsychopharmacol. 1997 Apr;7 Suppl 1:S57-70; discussion S71-3
pubmed: 9169311
J Neurogastroenterol Motil. 2015 Oct 1;21(4):537-44
pubmed: 26350938
Acta Neuropsychiatr. 2003 Aug;15(4):242-8
pubmed: 26983571
Int J Behav Med. 2012 Sep;19(3):308-15
pubmed: 21935740
Behav Ther. 2019 May;50(3):594-607
pubmed: 31030876
Psychosom Med. 1998 Jul-Aug;60(4):492-7
pubmed: 9710296
Psychol Med. 2011 Dec;41(12):2669-79
pubmed: 21477419
Gastroenterology. 2006 Apr;130(5):1480-91
pubmed: 16678561
J Psychosom Res. 2010 Sep;69(3):319-25
pubmed: 20708455
Am J Gastroenterol. 2010 Nov;105(11):2440-8
pubmed: 20551938
Gastroenterol Nurs. 2018 May/Jun;41(3):223-232
pubmed: 29847397
Aliment Pharmacol Ther. 1997 Apr;11(2):395-402
pubmed: 9146781
BMJ Open. 2015 Jul 15;5(7):e008622
pubmed: 26179651
Neurogastroenterol Motil. 2017 Apr;29(4):
pubmed: 27781332
Aliment Pharmacol Ther. 2004 Jul 1;20(1):89-97
pubmed: 15225175